Frontlight ResearchEarly access
Taking people in United StatesNo phase
Tests a lifestyle program tailored to individual profiles for obesity
Tests a tailored lifestyle program for weight loss in adults with obesity.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
- Status
- Recruiting
- People taking part
- 228 people, planned
- Started
- 22 Jan 2025
- Expected to end
- Dec 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Standard Lifestyle Intervention (SLI) program
- Phenotype-tailored Lifestyle Intervention (PLI) program
- Record updated
- 11 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men and women aged 18 to 65 who have obesity (BMI over 30 kg/m2).
- Age
- 18 to 65 years
- Sex
- Men and women
- Disease stage
- Obesity, with a BMI over 30 kg/m2
- Earlier treatment
- People who had bariatric surgery or bariatric endoscopy, who currently use AOMs, or who used medications affecting weight, energy intake or energy expenditure in the last 6 months cannot join.
Main reasons for not taking part
- Weight change greater than 3% in the previous 3 months
- History of bariatric surgery or bariatric endoscopy
- Untreated psychiatric disorders, including binge eating disorders and bulimia
- History of type 1 diabetes mellitus or uncontrolled medical conditions, such as uncontrolled hypertension
- Pregnant women or women who plan to become pregnant
The registry criteria, word for word
Show all 11 criteriaShow less
Other criteria
- Inclusion:
- men or women between 18 to 65 years with obesity (BMI>30kg/m2); Exclusion:
- weight change greater than 3% in the previous 3 months
- history of bariatric surgery and bariatric endoscopy
- untreated psychiatric disorders including binge eating disorders and bulimia
- current use of AOMs
- history of use of medications affecting weight or energy intake or energy expenditure in the last 6 months
- history of type 1 diabetes mellitus or uncontrolled medical conditions (e.g., uncontrolled hypertension)
- women who are pregnant or plan to become pregnant,
- any condition that limits their participation in the study
- Principal Investigator discretion
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in United States
- Mayo ClinicRochester, United StatesContact: Megan SchaeferTaking people
About the trial
What the trial wants to find out
The purpose of this study is to develop an evidence-based precision medicine approach for obesity that enhances weight loss and promotes weight loss maintenance.
The 2 groups in the trial
- Standard Lifestyle Intervention (SLI) programExisting treatment, for comparison
- Phenotype-tailored Lifestyle Intervention (PLI) programTreatment being tested
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
- Plain-language title
- Tests a lifestyle program tailored to individual profiles for obesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06770049, who can take part
- Record updated
- 11 June 2026